Cim, LLC Edwards Lifesciences Corp Transaction History

Cim, LLC

$685 Million
Q4 2024

A detailed history of Cim, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cim, LLC holds 189,399 shares of EW stock, worth $13.5 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares

189,399

Previous 187,062 1.25%

Holding current value

$13.5 Million

Previous $12.3 Million 13.59%

% of portfolio

2.05%

Previous 1.78%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Mar 03, 2025	BUY	$64.54 - $75.92 $150,829 - $177,425	2,337 Added 1.25%	189,399 $14 Million
Q3 2024 Jan 16, 2025	BUY	$59.7 - $93.78 $17,492 - $27,477	293 Added 0.16%	187,062 $12.3 Million
Q2 2024 Sep 06, 2024	BUY	$84.3 - $94.31 $222,636 - $249,072	2,641 Added 1.43%	186,769 $17.3 Million
Q1 2024 May 20, 2024	BUY	$72.54 - $95.56 $299,952 - $395,140	4,135 Added 2.3%	184,128 $17.6 Million
Q4 2023 Feb 23, 2024	SELL	$61.71 - $77.76 $635,181 - $800,383	-10,293 Reduced 5.41%	179,993 $13.7 Million
Q3 2023 May 17, 2024	SELL	$69.28 - $93.38 $377,991 - $509,481	-5,456 Reduced 2.91%	181,905 $12.6 Million
Q2 2023 May 17, 2024	BUY	$81.41 - $94.33 $599,828 - $695,023	7,368 Added 4.09%	187,361 $17.7 Million
Q1 2023 May 17, 2024	BUY	$74.26 - $84.51 $731,758 - $832,761	9,854 Added 5.47%	189,847 $15.7 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $2.01 Million - $2.58 Million	29,458 Added 18.32%	190,286 $14.2 Million
Q3 2022 Nov 02, 2022	SELL	$82.37 - $107.29 $218,857 - $285,069	-2,657 Reduced 1.63%	160,828 $11.7 Million
Q2 2022 Jul 11, 2022	SELL	$86.5 - $128.27 $228,100 - $338,247	-2,637 Reduced 1.59%	163,485 $16.1 Million
Q1 2022 Apr 12, 2022	SELL	$101.96 - $128.34 $1 Million - $1.26 Million	-9,850 Reduced 5.6%	166,122 $20.2 Million
Q4 2021 Jan 26, 2022	SELL	$106.37 - $130.68 $472,282 - $580,219	-4,440 Reduced 2.46%	175,972 $19.3 Million
Q3 2021 Nov 08, 2021	SELL	$102.91 - $122.75 $193,162 - $230,401	-1,877 Reduced 1.03%	180,412 $21.4 Million
Q2 2021 Aug 09, 2021	BUY	$83.84 - $104.76 $118,633 - $148,235	1,415 Added 0.78%	182,289 $21 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $942,271 - $1.09 Million	-11,976 Reduced 6.21%	180,874 $16.4 Million
Q4 2020 Feb 08, 2021	BUY	$71.69 - $91.23 $47,888 - $60,941	668 Added 0.35%	192,850 $16.4 Million
Q3 2020 Nov 06, 2020	BUY	$67.19 - $87.44 $169,184 - $220,173	2,518 Added 1.33%	192,182 $14.9 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $7.25 Million - $9.7 Million	126,002 Added 197.92%	189,664 $13.1 Million
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $7,442 - $11,502	-142 Reduced 0.22%	63,662 $12 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $776,582 - $889,116	-10,831 Reduced 14.51%	63,804 $14.9 Million
Q3 2019 Oct 15, 2019	SELL	$61.55 - $75.43 $206,931 - $253,595	-3,362 Reduced 4.31%	74,635 $16.4 Million
Q2 2019 Jul 22, 2019	SELL	$55.74 - $64.41 $4.32 Million - $4.99 Million	-77,428 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$47.89 - $64.05 $3.71 Million - $4.96 Million	77,428 New	77,428 $14.8 Million
Q4 2018 Jan 29, 2019	SELL	$46.41 - $56.94 $3.81 Million - $4.68 Million	-82,105 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$45.7 - $58.03 $480,215 - $609,779	-10,508 Reduced 11.35%	82,105 $14.3 Million
Q2 2018 Jul 10, 2018	SELL	$42.45 - $51.3 $19,017 - $22,982	-448 Reduced 0.48%	92,613 $13.5 Million
Q1 2018 Apr 05, 2018	BUY	$37.19 - $47.45 $141,991 - $181,164	3,818 Added 4.28%	93,061 $13 Million
Q4 2017 Jan 23, 2018	BUY	$33.79 - $39.39 $223,689 - $260,761	6,620 Added 8.01%	89,243 $10.1 Million
Q3 2017 Nov 03, 2017	SELL	$36.29 - $38.83 $13,391 - $14,328	-369 Reduced 0.44%	82,623 $9.03 Million
Q2 2017 Aug 09, 2017	BUY	N/A	82,992	82,992 $9.81 Million

Others Institutions Holding EW

# of Institutions

1,383

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cim, LLC with notifications on news.

Account